Baylor College of Medicine

Giving life to possible

Chapters and Other Publications

Alzheimer's Disease and Memory Disorders Center

Click on the Expand plus sign sign to list the book chapters and other publications by year. Then click on the link for details of that publication.

<2021

Collapse All | Expand All

 

  • Doody RS. Alzheimer's disease and mild cognitive impairment. In: Kass JS, Mizrahi EM, editors. Neurology secrets. 6th ed. Philadelphia: Elsevier; 2016. p. 191-200.
  • Hyman DJ, Vallbona C, Pavlik VN. Hypertension in Hispanics. In: Black HR, Elliott WJ, editors. Hypertension: A companion to Braunwald?s heart disease. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2013. p. 365-368.
  • Doody R. Dementia. In: Rolak LA, editor. Neurology secrets. 5th ed. Philadelphia: Mosby; 2010. p. 235-246.
  • Doody RS. Prevention and future treatment of Alzheimer's disease. In: Doody RS, editor. Alzheimer's dementia. Delray Beach (FLA): Carma Publishing; 2008. p. 115-140.
  • Hyman DJ, Vallbona C, Pisarik P, Pavlik VN. Hypertension in Hispanics. In: Black HR, Elliott WJ, editors. Hypertension: A companion to Braunwald?s heart disease. Philadelphia, PA: Saunders Elsevier; 2007.
  • Doody RS. Alzheimer's disease. In: Johnson RT, Griffin JW, McArthur JC, editors. Current therapy in neurologic disease. 7th ed. Philadelphia: Mosby, Inc.; 2006. p. 311-314.
  • Doody RS, Winblad B, Jelic V. Alzheimer's and related disorders annual 2003. In: Gauthier S, Scheltens P, Cummings J, editors. Neurodegenerative dementias. London: Martin Dunitz (Taylor & Francis); 2004. p. 137-144.
  • Hyman DJ, Pavlik VN. Maximizing blood pressure control and patient adherence. In: Egan BM, Basile J, Lackland D, editors. Hot topics in hypertension. Philadelphia, PA: Hanley and Belfus, Inc.; 2004.
  • Hyman DJ, Pavlik VN. Physician factors in hypertension control. In: Izzo Jr JL, Black HR, editors. American Heart Association Primer: The essentials of blood pressure control. 3rd ed. Baltimore, MD: Lippincott Williams & Wilkins; 2004.
  • Doody RS. Pathogenesis and treatment strategies for selected therapies in Alzheimer's disease. In: Iqbal K, Winblad B, editors. Alzheimer's disease and related disorders: research advances. Vol. 57. Bucharest, Romania: Ana Aslan International Academy of Aging; 2003. p. 633-638.
  • Hyman DJ, Pavlik VN. Barriers to blood pressure control. In: Izzo JL, Black HR, editors. Hypertension primer. 3rd ed. Dallas, Texas: American Heart Association; 2003. p. 402-405.
  • Grundman M, Kim H, Salmon D, Storandt M, Smith G, Ferris S, et al. The Alzheimer's disease center's neuropsychological database initiative: A resource for Alzheimer's disease prevention trials. In: Iqbal K, Sisodiya S, Winblad B, editors. Alzheimer's disease: advances in etiology, pathogenesis, therapeutics. New York: John Wiley & Sons; 2001. p. 129-140.
  • Doody RS. Treatment strategies in Alzheimer's disease. In: Trojanowski J, Clark C, editors. Neurodegenerative dementias. New York: McGraw-Hill; 2000. p. 115-126.
  • Hanna P, Doody RS. Alien limb syndrome. In: Litvan I, Goetz C, Lang A, editors. Corticobasal degeneration. 51st ed. Philadelphia: Lippincott-Raven, Inc.; 2000. p. 135-145.
  • Doody RS. Alzheimer's disease. In: Rakel R, editor. Conn's current therapy. 51st ed. Philadelphia: WB Saunders; 1999. p. 878-882.
  • Doody RS. Current therapeutic standards in the treatment of Alzheimer's disease. In: Vellas B, Fitten L, editors. Research and practice in AD. 51st ed. Paris: Serdi Publishing; 1999. p. 270-275.
  • Doody RS, Davidson M, Shoulson I, Whitehouse P. Harmonization of drug approval guidelines in Alzheimer's and Parkinson's diseases. In: Fisher A, Yorshida M, Hanin I, editors. Progress in Alzheimer's and Parkinson's diseases. New York: Plenum Press; 1998. p. 861-865.
  • Doody RS. Dementia. In: Rolak LA, editor. Neurology secrets. 2nd ed. Philadelphia: Hanley & Belfus; 1998. p. 199-208.
  • Doody RS. Test scores in clinical trials versus performance in real life: Can clinical global assessments bridge the gap? In: Winbladt B, Wimo A, Jonsson B, Karlsson G, editors. Health economics of dementia. Sussex: John Wiley & Sons, Ltd.; 1998. p. 311-325.
  • Doody RS. Cholinergic therapies in the treatment of Alzheimer's disease. Proceedings of the Fourth WHO-CC Symposium; Sendai, Japan. Sendai, Japan: WHO-CC Monograph; 1997. p. 75-82.
  • Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, et al. Validity and reliability of the Alzheimer's disease study-clinical global impression of change (ADCS-CGIC). In: Giacobini E, Becker RE, Phillipe R, editors. Alzheimer's disease: From molecular biology to therapy. Boston: Birkhauser; 1996. p. 425-429.
  • Doody RS, Massman PJ. Other extrapyramidal dementias. In: Morris JC, editor. Handbook of dementing illness. New York: Marcel Dekker, Inc.; 1994. p. 319-334.
  • Doody RS. Alien hand. In: Molgaard CA, editor. Neuroepidemiology: theory and method. San Diego: Academic Press; 1993. p. 181-193.
  • Pavlik VN, Laux L. Reliability of evaluation instruments in low-income, bilingual settings. In: Feldman RHL, Humphrey JH, editors. Advances in health education: Current research. Vol. 3. Ney York: AMS Press; 1993. p. 269-276.